CONTROL OF INFLUENZA VIA VACCINES: CHALLENGES AND PERSPECTIVES AS VIEWED BY VARIOUS STAKEHOLDERS

Código QR

CONTROL OF INFLUENZA VIA VACCINES: CHALLENGES AND PERSPECTIVES AS VIEWED BY VARIOUS STAKEHOLDERS

.

Guardado en:

Detalles Bibliográficos
Autor principal:	Y. M. Vasiliev
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/31e62bce1586456996de694b7ef29b64
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

SAPONIN TAUROSID Sx1 ADMINISTRATION ENHANCES ANTIBODY PRODUCTION IN MICE, CHALLENGED WITH INFLUENZA VIRUS OR IMMUNIZED WITH INFLUENZA GRIPPOL® VACCINE
por: V. Yu. Maligina, et al.
Publicado: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
por: D. A. Mezhenskaia, et al.
Publicado: (2018)

THE USE OF CORRELATION ANALYSIS ON THE EXAMPLE OF INFLUENZA VACCINATION ON THE TERRITORY OF THE ROSTOV REGION
por: S. S. Slis’, et al.
Publicado: (2018)

IMMUNIZATION WITH UNIVERSAL INFLUENZA VACCINE ENHANCES IMMUNE RESPONSE TO SUBSEQUENT INFECTION
por: M. A. Shuklina, et al.
Publicado: (2018)

RISK FACTORS FOR SARI AND INFLUENZA VACCINE EFFECTIVENESS IN SENTINEL SURVEILLANCE SYSTEM IN RUSSIA, THE SEASON 2017–2018
por: E. A. Smorodintseva, et al.
Publicado: (2018)

Stakeholder engagement is essential to maximise the impact of research on infant feeding in the context of HIV
por: Bakita Kasadha, et al.
Publicado: (2021)

Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine
por: Ailar Sabbaghi, et al.
Publicado: (2021)

CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
por: A. Budkowska
Publicado: (2018)

OPTIMIZATION OF EXPRESSION, PURIFICATION, AND STABILIZATION CONDITIONS FOR FLG-HA2-4M2E, A RECOMBINANT PROTEIN IN UNIVERSAL INFLUENZA VACCINE
por: A. A. Kovaleva, et al.
Publicado: (2018)

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
por: M. K. Erofeeva, et al.
Publicado: (2014)

Evaluating intimate partner violence and response system in leon, Nicaragua: Perspectives from survivors and stakeholders
por: J. Zelaya
Publicado: (2015)

COMPLIANCE OF HEALTH CARE WORKERS WITH VACCINATION AS THE FACTOR OF FORMATION OF POSITIVE ATTITUDE TOWARDS VACCINATION IN THE POPULATION
por: T. A. Platonova, et al.
Publicado: (2018)

EPIDEMIC RISE OF INFLUENZA IN ST. PETERSBURG IN JANUARY-MARCH 2018
por: M. A. Bichurina, et al.
Publicado: (2018)

MICROBIOLOGY AND IMMUNOLOGY, MODERN CHALLENGES
por: A. B. Zhebrun
Publicado: (2014)

ON THE TIMELINESS OF VACCINATION IN CHILDREN’S OUTPATIENT DEPARTMENT
por: A. A. Golubkova, et al.
Publicado: (2018)

DEVELOPMENT OF A NEW ANTI-INFLUENZA COMPOUND BASED ON CAMPHOR SCAFFOLD
por: V. V. Zarubaev, et al.
Publicado: (2018)

SENSITIVITY OF 2018 KAZAKHSTAN INFLUENZA TYPE B VIRUSES TO ANTIVIRAL DRUGS
por: G. V. Lukmanova, et al.
Publicado: (2018)

ETHICS OF VACCINATION AS THE CRITERIA OF THE SCIENTIFIC AND HUMANISTIC APPROACH
por: O. I. Kubar
Publicado: (2018)

IMPROVEMENT OF TECHNOLOGY OF PRODUCTION OF HERPETIC VACCINE, CULTURAL, INACTIVE
por: G. S. Shitikova, et al.
Publicado: (2018)

HLA GENE POLYMORPHISM IN PERSONS VACCINATED AGAINST PLAGUE
por: O. M. Kudryavtseva, et al.
Publicado: (2018)

THE ROLE OF MORAXELLA CATARRHALIS IN THE DEVELOPMENT OF COMPLICATIONS AFTER INFLUENZA AND OTHER ACUTE RESPIRATORY DISEASES
por: L. A. Kraeva, et al.
Publicado: (2018)

MOLECULAR DIAGNOSTICS OF TUBERCULOSIS: CLINICAL ASPECTS AND CHALLENGES OF IMPLEMENTATION
por: V. Zhuravlev
Publicado: (2018)

VACCINE PROPHYLAXIS, DIAGNOSTICS AND GENOTYPES OF MUMPS (EPIDEMIC PAROTITIS) VIRUS
por: N. V. Yuminova, et al.
Publicado: (2018)

RESULTS OF MOLECULAR DETECTION AND CHARACTERIZATION OF INFLUENZA AND OTHER RESPIRATORY VIRUSES IN RUSSIA, SEASON 2017–2018
por: A. A. Sominina, et al.
Publicado: (2018)

CLINICAL-LABORATORY CHARACTERISTICS OF INFLUENZA INFECTION IN HOSPITALIZED ADULT PATIENTS IN THE EPIDEMIC SEASON 2017–2018
por: L. V. Voloshchuk, et al.
Publicado: (2018)

CIRCULATION OF INFLUENZA VIRUSES AMONG HUMANS AND SWINE IN THE REGIONS OF NORTHERN AND WESTERN KAZAKHSTAN IN 2017–2018
por: S. B. Baiseiit, et al.
Publicado: (2018)

STUDY ON HERD IMMUNITY AGAINST INFLUENZA VIRUS AMONG THE POPULATION OF ALMATY REGION IN 2017–2018
por: A. M. Baimukhametova, et al.
Publicado: (2018)

Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom
por: Tonia Thomas, et al.
Publicado: (2021)

EVALUATION OF THE EFFECTIVENESS OF PNEUMOCOCCAL VACCINES FOR PREVENTION OF COMMUNITY-ACQUIRED PNEUMONIA IN SERVICEMEN
por: S. D. Zhogolev, et al.
Publicado: (2018)

MOLECULAR TYPING OF MYCOBACTERIUM KANSASII — A GLOBAL PERSPECTIVE
por: Z. Bakuła, et al.
Publicado: (2018)

Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic
por: Aurora Salamanca, et al.
Publicado: (2021)

CHALLENGES FOR POLIO ERADICATION. RISK OF RE-EMERGENCY OF INFECTION IN POLIO FREE COUNTRIES
por: N. I. Romanenkova, et al.
Publicado: (2018)

MONITORING OF VACCINAL PROCESS IN HUMANS RESIDING IN THE ALTAI HIGH-MOUNTAINOUS NATURAL PLAGUE FOCUS
por: K. M. Korytov, et al.
Publicado: (2018)

MEASLES IN YEKATERINBURG: THE HISTORICAL PATH FROM THE PERIOD BEFORE VACCINATION TO THE STAGE OF ELIMINATION OF THE INFECTION
por: A. A. Golubkova, et al.
Publicado: (2018)

POTENTIAL INFLUENCE OF IMMUNOMODULATORS ON THE PRODUCTION OF INTERFERON-GAMMA AND INTERLEUKIN-10 IN LABORATORY ANIMALS VACCINATED AGAINST PLAGUE
por: A. Yu. Goncharova, et al.
Publicado: (2018)

EMERGENCE OF VACCINE-DERIVED POLIOVIRUSES DURING EBOL A VIRUS DISEASE OUTBREAK IN GUINEA, 2014–2015
por: M. D. Fernandez-Garcia, et al.
Publicado: (2018)

Parental factors associated with influenza school located vaccination program in the United States
por: G. Kang, et al.
Publicado: (2015)

ENVIRONMENTAL AND HUMAN SURVEILLANCE OF POLIOVIRUSES AND OTHER ENTEROVIRUSES IN MADAGASCAR. IMPACT OF THE TRIVALENT TO BIVALENT ORAL POLIO VACCINE SWITCH
por: M.-L. Joffret, et al.
Publicado: (2018)

ANTI-PLAGUE VACCINATION STIMULATES THE NEUTROPHIL EXTRACELLULAR TRAPS FORMATION TO INCREASE THE YERSINIA PESTIS KILLING EFFICIENCY IN VIVO
por: A. L. Kravtsov, et al.
Publicado: (2018)

EVOLUTION OF THE VP1 REGION TYPE 2 VACCINE-DERIVED POLIOVIRUS SHEDDING FROM AN IMMUNOCOMPROMISED ALGERIAN CHILD
por: D. Boulahbal-Anes, et al.
Publicado: (2018)